{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:51:24Z","timestamp":1779889884833,"version":"3.53.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":554,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ygeno.2020.12.030","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T10:19:00Z","timestamp":1608891540000},"page":"507-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study"],"prefix":"10.1016","volume":"113","author":[{"given":"Mu-Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Feng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ta","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Jee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Mei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Ping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygeno.2020.12.030_bb0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.biopsych.2018.07.018","article-title":"Mechanisms of the antidepressant effects of ketamine enantiomers and their metabolites","volume":"84","author":"Ide","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0015","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0025","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/bja\/aeg028","article-title":"Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury","volume":"90","author":"Hijazi","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0035","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.4088\/JCP.13m08698","article-title":"Clinical predictors of ketamine response in treatment-resistant major depression","volume":"75","author":"Niciu","year":"2014","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15040771","article-title":"Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder","volume":"15","author":"Rong","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jad.2019.03.075","article-title":"Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)","volume":"251","author":"Chen","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.ygeno.2020.12.030_bb0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/ijnp\/pyaa030","article-title":"Effects of mu-opiate receptor gene polymorphism rs1799971 (A118G) on the antidepressant and dissociation responses in esketamine nasal spray clinical trials","volume":"23","author":"Saad","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0055","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.biopsych.2012.05.031","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients","volume":"72","author":"Laje","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-018-0311-7","article-title":"Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression","volume":"8","author":"Guo","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0065","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.1038\/s41598-020-69291-6","article-title":"Genome-wide association study and polygenic risk score analysis of esketamine treatment response","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0070","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/hbm.23085","article-title":"The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study","volume":"37","author":"Li","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajhg.2010.06.009","article-title":"A versatile gene-based test for genome-wide association studies","volume":"87","author":"Liu","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: A rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0095","article-title":"Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling","author":"Qu","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","article-title":"How do antidepressants work? New perspectives for refining future treatment approaches","volume":"4","author":"Harmer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","article-title":"The neurology of mTOR","volume":"84","author":"Lipton","year":"2014","journal-title":"Neuron."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0110","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0115","series-title":"Ketamine","article-title":"Effects of adjunctive ketamine intravenous infusion in Taiwanese patients with treatment-resistant depression: Antidepression, antisuicidality, BDNF Val66Met, and brain imaging","author":"Chen","year":"2020"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-019-05346-5","article-title":"MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: A role of TrkB signaling","volume":"237","author":"Fujita","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2015.06.033","article-title":"Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT","volume":"186","author":"Allen","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.2271","article-title":"Single ketamine infusion in bipolar depression resistant to antidepressants: Are neurotrophins involved?","volume":"28","author":"Rybakowski","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.8","article-title":"Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: A 3-year follow-up study","volume":"6","author":"Hashimoto","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0140","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/ajad.12984","article-title":"GRIN2B gene polymorphism in chronic ketamine users","volume":"29","author":"Fan","year":"2020","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.ygeno.2020.12.030_bb0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/mp.2015.114","article-title":"Sex differences in glutamate receptor gene expression in major depression and suicide","volume":"20","author":"Gray","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0155","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00213-013-3297-0","article-title":"A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression","volume":"231","author":"Zhang","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0160","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/mp.2012.112","article-title":"Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: Associations and gene-environment interactions with childhood\/adolescent physical assault","volume":"18","author":"Sokolowski","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0170","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/mp.2009.24","article-title":"Population genetic study of the brain-derived neurotrophic factor (BDNF) gene","volume":"15","author":"Petryshen","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ygeno.2020.12.030_bb0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajmg.b.20118","article-title":"Ethnic difference of the BDNF 196G\/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits","volume":"126B","author":"Shimizu","year":"2004","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."}],"updated-by":[{"DOI":"10.1016\/j.ygeno.2021.10.017","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754320320772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754320320772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:25:57Z","timestamp":1760163957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0888754320320772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0888754320320772"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2020.12.030","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ygeno.2021.10.017","asserted-by":"object"}]},"ISSN":["0888-7543"],"issn-type":[{"value":"0888-7543","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2020.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}